FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2804670096> ?p ?o ?g. }

• W2804670096 endingPage "148" @default.
• W2804670096 startingPage "137" @default.
• W2804670096 abstract "Co-crystal of tramadol–celecoxib (CTC), containing equimolar quantities of the active pharmaceutical ingredients (APIs) tramadol and celecoxib (100 mg CTC = 44 mg rac–tramadol hydrochloride and 56 mg celecoxib), is a novel API-API co-crystal for the treatment of pain. We aimed to establish the effective dose of CTC for treating acute pain following oral surgery. A dose-finding, double-blind, randomised, placebo- and active-controlled, multicentre (nine Spanish hospitals), phase II study (EudraCT number: 2011-002778-21) was performed in male and female patients aged ≥ 18 years experiencing moderate to severe pain following extraction of two or more impacted third molars requiring bone removal. Eligible patients were randomised via a computer-generated list to receive one of six single-dose treatments (CTC 50, 100, 150, 200 mg; tramadol 100 mg; and placebo). The primary efficacy endpoint was the sum of pain intensity difference (SPID) over 8 h assessed in the per-protocol population. Between 10 February 2012 and 13 February 2013, 334 patients were randomised and received study treatment: 50 mg (n = 55), 100 mg (n = 53), 150 mg (n = 57), or 200 mg (n = 57) of CTC, 100 mg tramadol (n = 58), or placebo (n = 54). CTC 100, 150, and 200 mg showed significantly higher efficacy compared with placebo and/or tramadol in all measures: SPID (0–8 h) (mean [standard deviation]): − 90 (234), − 139 (227), − 173 (224), 71 (213), and 22 (228), respectively. The proportion of patients experiencing treatment-emergent adverse events was lower in the 50 (12.7% [n = 7]), 100 (11.3% [n = 6]), and 150 (15.8% [n = 9]) mg CTC groups, and similar in the 200 mg (29.8% [n = 17]) CTC group, compared with the tramadol group (29.3% [n = 17]), with nausea, dizziness, and vomiting the most frequent events. Significant improvement in the benefit–risk ratio was observed for CTC (doses ≥ 100 mg) over tramadol and placebo in the treatment of acute pain following oral surgery. Laboratorios del Dr. Esteve, S.A.U." @default.
• W2804670096 created "2018-06-01" @default.
• W2804670096 creator A5000848732 @default.
• W2804670096 creator A5017942117 @default.
• W2804670096 creator A5022967694 @default.
• W2804670096 creator A5024928859 @default.
• W2804670096 creator A5039331712 @default.
• W2804670096 creator A5042779183 @default.
• W2804670096 creator A5044442876 @default.
• W2804670096 creator A5054592912 @default.
• W2804670096 creator A5067499356 @default.
• W2804670096 creator A5069422042 @default.
• W2804670096 creator A5073312224 @default.
• W2804670096 creator A5078322238 @default.
• W2804670096 creator A5084304065 @default.
• W2804670096 creator A5086217522 @default.
• W2804670096 date "2018-05-25" @default.
• W2804670096 modified "2023-10-13" @default.
• W2804670096 title "Co-crystal of Tramadol–Celecoxib in Patients with Moderate to Severe Acute Post-surgical Oral Pain: A Dose-Finding, Randomised, Double-Blind, Placebo- and Active-Controlled, Multicentre, Phase II Trial" @default.
• W2804670096 cites W1580329127 @default.
• W2804670096 cites W1914796391 @default.
• W2804670096 cites W1965918637 @default.
• W2804670096 cites W1982478654 @default.
• W2804670096 cites W2007440728 @default.
• W2804670096 cites W2015335835 @default.
• W2804670096 cites W2072369333 @default.
• W2804670096 cites W2103793045 @default.
• W2804670096 cites W2112224102 @default.
• W2804670096 cites W2116132316 @default.
• W2804670096 cites W2117502536 @default.
• W2804670096 cites W2137079617 @default.
• W2804670096 cites W2141258812 @default.
• W2804670096 cites W2145887563 @default.
• W2804670096 cites W2148381133 @default.
• W2804670096 cites W2257876134 @default.
• W2804670096 cites W2266327968 @default.
• W2804670096 cites W2270927172 @default.
• W2804670096 cites W2594837965 @default.
• W2804670096 cites W2750323361 @default.
• W2804670096 cites W2751977187 @default.
• W2804670096 doi "https://doi.org/10.1007/s40268-018-0235-y" @default.
• W2804670096 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5995791" @default.
• W2804670096 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29799099" @default.
• W2804670096 hasPublicationYear "2018" @default.
• W2804670096 type Work @default.
• W2804670096 sameAs 2804670096 @default.
• W2804670096 citedByCount "26" @default.
• W2804670096 countsByYear W28046700962018 @default.
• W2804670096 countsByYear W28046700962019 @default.
• W2804670096 countsByYear W28046700962020 @default.
• W2804670096 countsByYear W28046700962021 @default.
• W2804670096 countsByYear W28046700962022 @default.
• W2804670096 countsByYear W28046700962023 @default.
• W2804670096 crossrefType "journal-article" @default.
• W2804670096 hasAuthorship W2804670096A5000848732 @default.
• W2804670096 hasAuthorship W2804670096A5017942117 @default.
• W2804670096 hasAuthorship W2804670096A5022967694 @default.
• W2804670096 hasAuthorship W2804670096A5024928859 @default.
• W2804670096 hasAuthorship W2804670096A5039331712 @default.
• W2804670096 hasAuthorship W2804670096A5042779183 @default.
• W2804670096 hasAuthorship W2804670096A5044442876 @default.
• W2804670096 hasAuthorship W2804670096A5054592912 @default.
• W2804670096 hasAuthorship W2804670096A5067499356 @default.
• W2804670096 hasAuthorship W2804670096A5069422042 @default.
• W2804670096 hasAuthorship W2804670096A5073312224 @default.
• W2804670096 hasAuthorship W2804670096A5078322238 @default.
• W2804670096 hasAuthorship W2804670096A5084304065 @default.
• W2804670096 hasAuthorship W2804670096A5086217522 @default.
• W2804670096 hasBestOaLocation W28046700961 @default.
• W2804670096 hasConcept C126322002 @default.
• W2804670096 hasConcept C142724271 @default.
• W2804670096 hasConcept C168563851 @default.
• W2804670096 hasConcept C197934379 @default.
• W2804670096 hasConcept C203092338 @default.
• W2804670096 hasConcept C204787440 @default.
• W2804670096 hasConcept C27081682 @default.
• W2804670096 hasConcept C2776467144 @default.
• W2804670096 hasConcept C2779777798 @default.
• W2804670096 hasConcept C2780820201 @default.
• W2804670096 hasConcept C2908647359 @default.
• W2804670096 hasConcept C2910896220 @default.
• W2804670096 hasConcept C42219234 @default.
• W2804670096 hasConcept C71924100 @default.
• W2804670096 hasConcept C99454951 @default.
• W2804670096 hasConceptScore W2804670096C126322002 @default.
• W2804670096 hasConceptScore W2804670096C142724271 @default.
• W2804670096 hasConceptScore W2804670096C168563851 @default.
• W2804670096 hasConceptScore W2804670096C197934379 @default.
• W2804670096 hasConceptScore W2804670096C203092338 @default.
• W2804670096 hasConceptScore W2804670096C204787440 @default.
• W2804670096 hasConceptScore W2804670096C27081682 @default.
• W2804670096 hasConceptScore W2804670096C2776467144 @default.
• W2804670096 hasConceptScore W2804670096C2779777798 @default.
• W2804670096 hasConceptScore W2804670096C2780820201 @default.
• W2804670096 hasConceptScore W2804670096C2908647359 @default.
• W2804670096 hasConceptScore W2804670096C2910896220 @default.
• W2804670096 hasConceptScore W2804670096C42219234 @default.
• W2804670096 hasConceptScore W2804670096C71924100 @default.

• next